THC — TENET HEALTHCARE CORP

Ownership history in Freestone Grove Partners LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which Freestone Grove Partners LP reported a position in TENET HEALTHCARE CORP (THC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.38% (2025 Q1)
Avg. % of fund
0.3%
First filed
2025 Q1
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 134,197 -93,833 -41.1% 0.20% $27.2M $203.04
2025 Q2 REDUCED 228,030 -49,468 -17.8% 0.30% $40.1M $176.00
2025 Q1 INITIATED 277,498 — — 0.38% $37.3M $134.50
% of Fund (quarterly)    THC price (monthly, adj. close)

Other funds also holding THC

As of 2025 Q4 — sorted by position size

Khrom Capital Management LLC 3Y 10.42% GLENVIEW CAPITAL MANAGEMENT, LLC 3Y 7Y 8.02% PFM Health Sciences, LP 3Y 7Y 7.88% Amitell Capital Pte Ltd 3Y 7.78% WINSLOW ASSET MANAGEMENT INC 3Y 7Y 4.39% KESTREL INVESTMENT MANAGEMENT CORP 3Y 7Y 3.1% Steamboat Capital Partners, LLC 3Y 7Y 2.8% LONE PINE CAPITAL LLC 3Y 7Y 2.61% Dorsey Wright & Associates 3Y 7Y 2.32% Sivik Global Healthcare LLC 3Y 7Y 2.16%
← Back to Freestone Grove Partners LP Holdings